Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
The Pharmaceutical Market: Namibia

Namibia pharmaceutical market: New market research published


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-03-13 15:04:02 - The Pharmaceutical Market: Namibia - a new market research report on companiesandmarkets.com

Namibia has many of the qualities exhibited by frontier pharmaceutical markets: very low per capita spending on medicines, limited access to healthcare facilities, a high prevalence of communicable diseases and constrained ability to pay for advanced therapeutics. Nevertheless, due to low growth rates in developed states, multinational drugmakers are increasingly displaying interest, albeit tentatively, in Namibia.

Headline Expenditure Forecasts

Pharmaceuticals:NAD1.98bn (US$273mn) in 2011 to NAD2.19bn (US$268mn) in 2012; +11.0% in local currency and -1.7% in US dollar terms. Forecast slightly down in local currency terms and US dollar terms due to macroeconomic factors and Namibian dollar weakness, respectively.

Healthcare:NAD5.53bn (US$761mn) in 2011 to NAD5.94bn (US$725mn) in 2012; +7.4% in local currency and -4.8% in US dollar terms. Forecast slightly down in local currency

 

 

terms and US dollar terms due to macroeconomic factors and Namibian dollar weakness, respectively.

Medical Devices: NAD0.62bn (US$85mn) in 2011 to NAD0.69bn (US$84mn) in 2012; +11.0% in local currency terms and -1.7% in US dollar terms. Forecast slightly down in local currency terms and US dollar terms due to macroeconomic factors and Namibian dollar weakness, respectively.

Risk/Reward Ratings

Within the Middle East and Africa region, Namibia represents a moderately attractive proposition to foreign drugmakers, scoring 44.8 out of 100 in BMI´s proprietary rankings system. This is just above the regional average of 44.2. Although the market is small in absolute terms, there is relative economic and political stability, and the government is increasing its commitment to the provision of healthcare.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com